Sohn JH - Search Results

1

Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-Small Cell Lung Cancer.

Kim YJ, Sohn JH, Kim C, Kim YT, Kim HJ, Ahn JB, Kim SK, Chang J, Yoo NC, Kim JH, Cho JY. Kim YJ, et al. Among authors: sohn jh. Cancer Res Treat. 2003 Aug;35(4):294-8. doi: 10.4143/crt.2003.35.4.294. Cancer Res Treat. 2003. PMID: 26680950

2

Phase II Study of Topotecan and Etoposide as Second-line Treatment in Chemotherapy-refractory Small-cell Lung Cancer.

Kim C, Sohn JH, Kim JH, Kim SK, Kim YS, Chang J, Cho JY. Kim C, et al. Among authors: sohn jh. Cancer Res Treat. 2002 Oct;34(5):334-8. doi: 10.4143/crt.2002.34.5.334. Cancer Res Treat. 2002. PMID: 26680884

3

The Effect of ZD 1839 (Iressa(R)) in the Treatment of Refractory Non Small Cell Lung Cancer.

Kim YT, Kim C, Sohn JH, Park SY, Park SY, Yu NC, Kim YS, Kim SK, Chang J, Kim KD, Chung KY, Kim JH. Kim YT, et al. Among authors: sohn jh. Cancer Res Treat. 2003 Dec;35(6):502-6. doi: 10.4143/crt.2003.35.6.502. Cancer Res Treat. 2003. PMID: 26680982

4

Paclitaxel and Cisplatin Combination Chemotherapy in Pretreated Breast Cancer.

Sohn JH, Kim YT, Rha SY, Yoo NC, Roh JK, Kim BS, Suh CO, Kim GE, Jang WI, Chung HC. Sohn JH, et al. Cancer Res Treat. 2003 Jun;35(3):267-73. doi: 10.4143/crt.2003.35.3.267. Cancer Res Treat. 2003. PMID: 26680946

5

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer.

Sohn JH, Moon YW, Lee CG, Kim GE, Chung KY, Chang J, Kim SK, Kim YS, Choi BW, Choi HJ, Kim JH. Sohn JH, et al. Cancer. 2007 May 1;109(9):1845-950. doi: 10.1002/cncr.22621. Cancer. 2007. PMID: 17366589 Free article. Clinical Trial.

6

Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer.

Moon YW, Choi SH, Kim YT, Sohn JH, Chang J, Kim SK, Park MS, Chung KY, Lee HJ, Kim JH. Moon YW, et al. Among authors: sohn jh. Cancer. 2007 May 1;109(9):1829-35. doi: 10.1002/cncr.22601. Cancer. 2007. PMID: 17366594 Free article.

7

Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy.

Choi HJ, Cho BC, Shin SJ, Cheon SH, Jung JY, Chang J, Kim SK, Sohn JH, Kim JH. Choi HJ, et al. Among authors: sohn jh. Cancer Chemother Pharmacol. 2008 Feb;61(2):309-13. doi: 10.1007/s00280-007-0505-9. Epub 2007 Jun 19. Cancer Chemother Pharmacol. 2008. PMID: 17576560

8

Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib.

Cho BC, Im CK, Park MS, Kim SK, Chang J, Park JP, Choi HJ, Kim YJ, Shin SJ, Sohn JH, Kim H, Kim JH. Cho BC, et al. Among authors: sohn jh. J Clin Oncol. 2007 Jun 20;25(18):2528-33. doi: 10.1200/JCO.2006.10.4166. J Clin Oncol. 2007. PMID: 17577030 Clinical Trial.

9

A feasibility study of adenosine triphosphate-based chemotherapy response assay (ATP-CRA) as a chemosensitivity test for lung cancer.

Kang SM, Park MS, Chang J, Kim SK, Kim H, Shin DH, Chung KY, Kim DJ, Sohn JH, Choi SH, Kim J, Yoon EJ, Kim JH. Kang SM, et al. Among authors: sohn jh. Cancer Res Treat. 2005 Aug;37(4):223-7. doi: 10.4143/crt.2005.37.4.223. Epub 2005 Aug 31. Cancer Res Treat. 2005. PMID: 19956518 Free PMC article.

10

A Phase II Study of Gemcitabine Monotherapy in Breast Cancer Patients Refractory to Anthracycline and Taxane.

Park JY, Kim C, Sohn JH, Kim YT, Rha SY, Jang WI, Kim GE, Chung HC. Park JY, et al. Among authors: sohn jh. Cancer Res Treat. 2002 Aug;34(4):274-9. doi: 10.4143/crt.2002.34.4.274. Cancer Res Treat. 2002. PMID: 26680875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

987 results

Search Page

Filters